The resulting values ranged from 6.13 to 15.85 µM, which places studied derivatives as moderate or weak inhibitors of CYP3A4. BZP and TFMPP are amphetamine-like recreational drugs and the major active components of ‘party pills’. The pharmacodynamic effects of these neurally active drugs are thought to be dependent on their activity at DA and 5-HT receptors and several studies report drug-drug interactions at a pharmacodynamic level. Their metabolism involves the hepatic P450 enzymes CYP2D6, CYP1A2 and CYP3A4 resulting in inhibited metabolism of other drugs and medicines, as well as compromised metabolism in poor metabolisers for CYP2D6. Basic pharmacokinetic properties are described for both BZP and TFMPP when taken alone and in combination.
It is known that 1,4-dibenzylpiperazine (DBZP) can be formed as a side-product in this reaction. Piperazine derivatives are usually found in illicit dosage forms as either tablets or capsules, but loose powders also occur. The tablets often carry logos similar to those seen on ‘ecstasy’ tablets. There are no licensed medicinal products in the EU containing BZP or any of the other substances considered here. In the presented studies, analyses were performed using the buffer concentrations of 10 mM, 20 mM and 100 mM.
10 LC-DAD Analysis—Analytical Limits
- Many participants had reduced the frequency with which they used BZP-party pills due to adverse effects.
- Management strategies are often limited to supportive and symptomatic care due to the limited published data on alternative treatment approaches.
- “The pills… are advertised as safe, legal alternatives to illegal highs. There is no age restriction on sales,” according to a drug authority interviewed in the Ashburton Guardian.
- The stimulant effects are a result of the action of BZP, and hallucinations have been observed after TFMPP 29.
- The suitability of these methods for the evaluation of 1-aryl piperazines as metabolites of parent therapeutic drugs can be investigated in the future.
There is limited information available on the molecular mechanism of BZP, but this drug elicits amphetamine-like behavioral effects in rodents (Jones et al, 1980) and humans (Bye et al, 1973). No scientific investigations regarding the neurobiology of BZP plus TFMPP (BZP/TFMPP) are available. Thus, the aim of the present study was to examine the effects of BZP and TFMPP on monoamine neurotransmission in rat brain. In particular, we compared the effects of MDMA, BZP, and TFMPP on transporter-mediated release of DA and 5-HT using in vitro and in vivo neurochemical methods. Because BZP and TFMPP are reportedly coadministered by human drug users, we examined the effects of these agents alone and in combination. The identification of piperazine designer drugs is also necessary to predict interactions and inter-individual differences in pharmacokinetic profiles.
DrugFacts
For more on the legal issues posed by party pills, see benzylpiperazine. Matt Bowden, one of the original distributors of such pills4 was interviewed when issues involving party pills arose in the media. A clinical trial by ClubStargate for a pill named Ease was suspended because it contained methylone, which was claimed by the Ministry of Health to fall under New Zealand controlled drug analogue laws (although this was never proven in court). Piperazines have been described as ‘failed pharmaceuticals’, as some had been evaluated as potential therapeutic agents by pharmaceutical companies but never brought to the market 1. One piperazine that has been commonly used as NPS is 1-benzylpiperazine (BZP) though other piperazine derivatives have also been reported. These include among others 1-(3-chlorophenyl) piperazine (mCPP), 1-(3-trifluoromethylphenyl) piperazines (TFMPP), 1-benzyl-4-methylpiperazine (MBZP), 1-(4-fluorophenyl) piperazines (pFPP) and 1-cyclohexyl-4-(1,2-diphenylethyl) piperazine (MT-45).
- As mentioned previously, activation of 5-HT2A receptors by endogenous 5-HT contributes to MDMA-induced increases in extracellular DA (Schmidt et al, 1994; Gudelsky and Nash, 1996).
- It has been observed that metabolites can sometimes be more toxic than the original drug 66.
- Difficulty in assessing the results obtained can be due to the fact that the metabolic processes of related therapeutic drugs may result in the detection of 1-aryl-piperazines in the biological matrices 86.
- The chromatography has been optimized with an eluent gradient, obtaining a good peak shape and good separation of analytes.
Latest Data
Stimulants mediate the actions of dopamine, norepinephrine and/or serotonin, mimicking the effects of traditional drugs such as cocaine, amphetamine, methamphetamine, and ecstasy. Opioids belong to a chemically diverse group of central nervous system depressants. They bear structural features that allow binding to specific opioid receptors, resulting in morphine-like effects e.g. analgesia.
Ecstasy Metabolites And Monoamine Neurotransmitters Upshift The Na+/K+ ATPase Activity In Mouse Brain Synaptosomes
Confirmation of the identity of compounds causing the poisoning is essential in saving lives. The reproducibility of the method was assessed by using control samples at three empirically determined concentration levels of piperazine designer drugs in the linear range of the calibration curve. The reproducibility of peak areas of the piperazine derivatives and the retention times were assessed within the day and between different days. The piperazine-based hallucinogenic and stimulant compounds are abused, yet not used therapeutically 9,27,33. When identifying individual piperazine derivatives in biological material, it is necessary to analyze the circumstances of the event in order to correctly evaluate and interpret the result. Some piperazine designer drugs may be found in biological fluids as metabolites of related therapeutic drugs.
In vitro data have been utilized to predict clinical outcomes (i.e., pharmacokinetic interactions), with close correlations between in vitro and in vivo data. This information can be of considerable practical assistance to clinicians, to help with rational prescribing or to prevent or minimize the potential for drug interactions. In the United States, the Controlled Substances Act (CSA) of 1970 called for the assignment of all controlled drug substances into one of five categories called schedules.
Subjective Effects
Piperazines are usually available in the form of pills (regularly pressed with logos similar to ecstasy pills), capsules or loose powders, and are mainly consumed by ingestion. Liquid forms are rarely seen, but injection, smoking and snorting is also possible. UV-VIS spectra of benzyl- and phenyl derivatives of piperazine and pentedrone. 2 Abusers who deny consumption or have concurrent offences may face prosecution in lieu of rehabilitation.
Effects Of MDMA Administration In Vivo
Loss of substrate was determined by analysing pre- and post-incubation concentrations in the samples by using HPLC/UV analysis. Both TFMPP and BZP were found to inhibit the metabolism of dextromethorphan, caffeine, and ethinyloestradiol. These are reported substrates of CYP2D6, CYP1A2, and CYP3A4 respectively.
Legal Status TFMPP
It is feasible that TFMPP did not decrease motor activity in our experiments because rats were already habituated to housing conditions with an overnight acclimation period. Administration of BZP stimulated a parallel rise in extracellular DA and 5-HT in vivo, but effects on DA were always predominant (see Figure 6). The profile of BZP-induced increases in dialysate DA and 5-HT is reminiscent of the effects of methamphetamine (Baumann et al, 2002), though BZP is less potent. It seems surprising that BZP produces elevations in dialysate 5-HT in vivo, since the drug was inactive when tested as a releaser of 3H5-HT in vitro. However, we have noted inconsistencies between in vitro and in vivo effects of monoamine releasers in prior studies. Methamphetamine, for example, displays nearly 30-fold greater potency as a releaser of 3HDA vs 3H5-HT in synaptosomes (Rothman et al, 2001), yet low i.v.
Benzylpiperazine/Trifluoromethyl-phenylpiperazine
Piperazine designer drugs show affinity for many 5-HT receptor subtypes 9,21,22. Their hallucinogenic properties are the result of interaction with the 5-HT2A receptor, which may additionally lead to changes in the functioning of sensory processes 4,23. High doses of BZP when bound to the 5-HT2 receptor, produce an effect approximately 10 times weaker than that of MDMA 24,25,26.
On the other hand, TFMPP has insignificant affinity towards 5-HT3 receptor. It also affects release of acetylcholine and the release and uptake of monoaminergic neurotransmitters (dopamine, norepinephrine). Due to the specific effects of TFMPP on serotonergic neurotransmission, it induces hallucination, psychotropic effect, anxiety, nociceptic effect, hypothermia, hypotension, and bradycardia.
